A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing.

Joyce K Hwang Daniel J Marston Daniel WrappDapeng LiMarina Tuyishime Simon BrackenridgeBrianna RhodesMax QuastelA Brenda KapingidzaJacob GaterAustin HarnerYunfei WangWes RountreeGuido FerrariPersephone BorrowAndrew J McMichaelGeraldine M GillespieBarton F HaynesMihai L Azoitei

Published in: bioRxiv : the preprint server for biology (2024)

A high affinity monoclonal antibody against HLA-E-VL9 enhances natural killer cell anti-tumor killing by checkpoint inhibition and antibody dependent cellular cytotoxicity.

Keyphrases

monoclonal antibody
single cell
cell therapy
dna damage
cell cycle